Related references
Note: Only part of the references are listed.The roles of TLRs, RLRs and NLRs in pathogen recognition
Taro Kawai et al.
INTERNATIONAL IMMUNOLOGY (2009)
Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids
Xinyan Liu et al.
ATHEROSCLEROSIS (2008)
Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve
D. Versteeg et al.
HEART (2008)
Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events
Adam E. Mullick et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A
Ni Cheng et al.
JOURNAL OF IMMUNOLOGY (2008)
Translating molecular discoveries into new therapies for atherosclerosis
Daniel J. Rader et al.
NATURE (2008)
Toll-Like Receptor-2 Mediates Diet and/or Pathogen Associated Atherosclerosis: Proteomic Findings
Monika Madan et al.
PLOS ONE (2008)
Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells:: a phenomenon absent from murine cell systems
Anna M. Lundberg et al.
BLOOD (2007)
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Toll receptor polymorphisms and carotid artery intima-media thickness
Robyn Labrum et al.
STROKE (2007)
Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced NF-κB activation and cytokine production in primary human cells:: TRAM is an adaptor for LPS and LTA signaling
Sandra M. Sacre et al.
JOURNAL OF IMMUNOLOGY (2007)
Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease
SJ Ott et al.
CIRCULATION (2006)
Atherosclerosis and proteinase activation
CM Dollery et al.
CARDIOVASCULAR RESEARCH (2006)
Modulation of atherosclerosis in mice by Toll-like receptor 2
AE Mullick et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Regulation of lung injury and repair by Toll-like receptors and hyaluronan
DH Jiang et al.
NATURE MEDICINE (2005)
The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages
L Schaefer et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis
L Hamann et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Expansion of circulating toll-like receptor 4-positive monocytes in patients with acute coronary syndrome
H Methe et al.
CIRCULATION (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development
AH Schoneveld et al.
CARDIOVASCULAR RESEARCH (2005)
Toll-like receptors, endogenous ligands, and systemic autoimmune disease
IR Rifkin et al.
IMMUNOLOGICAL REVIEWS (2005)
Characterization of the expression of TLR2 (Toll-like receptor 2) and TLR4 on circulating monocytes in coronary artery disease
K Ashida et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2005)
Conditional signaling by Toll-like receptor 4
GJ Brunn et al.
FASEB JOURNAL (2005)
Canonical pathway of nuclear factor κB activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis
C Monaco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways
H Björkbacka et al.
NATURE MEDICINE (2004)
Distinct pathways of LPS-induced NF-κB activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP
E Andreakos et al.
BLOOD (2004)
Toll-like receptor 4 is involved in outward arterial remodeling
SCG Hollestelle et al.
CIRCULATION (2004)
Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction
K Edfeldt et al.
EUROPEAN HEART JOURNAL (2004)
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
KS Michelsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF
KA Fitzgerald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway
M Yamamoto et al.
NATURE IMMUNOLOGY (2003)
Toll-like receptor 4 polymorphisms and atherogenesis
S Kiechl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size
CM Devlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
HSP70 as endogenous stimulus of the toll/interleukin-1 receptor signal pathway
RM Vabulas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression of toll-like receptors in human atherosclerotic lesions - A possible pathway for plaque activation
K Edfeldt et al.
CIRCULATION (2002)
Share Paper
